Yuncheng Traditional Chinese Medicine Hospital
7
2
2
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
29%
2 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Registry for the Management of Helicobacter Pylori Infection in Shandong Province
Role: collaborator
P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication
Role: collaborator
Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses
Role: collaborator
Comparison of Two Dual Therapies in the First-line Treatment of Helicobacter Pylori Infection （SHARE2301）
Role: collaborator
Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.
Role: collaborator
The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori Infection
Role: collaborator
The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori Infection
Role: collaborator
All 7 trials loaded